Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

P. Cannon, Christopher; A. Blazing, Michael; P. Giugliano, Robert; McCagg, Amy; A. White, Jennifer; Théroux, Pierre; Darius, Harald; S. Lewis, Basil; Oude Ophuis, Ton; Wouter Jukema, J.; Maria De Ferrari, Gaetano; Rużyłło, Witold; De Lucca, Paul; Im, KyungAh; A. Bohula, Erin; Reist, Craig; D. Wiviott, Stephen; M. Tershakovec, Andrew; A. Musliner, Thomas; Braunwald, Eugene; M. Califf, Robert

doi:10.1056/nejmoa1410489

Public

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

Published in New England Journal of Medicine • Jun 4, 2015

Authors:

Christopher P. Cannon

Michael A. Blazing

Robert P. Giugliano

Abstract

BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of cardiovascular events further is not known. METHOD...

Subject

Ezetimibe

Medicine

Acute coronary syndrome

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!